Table of Contents

Clinical Studies

• You have access

  Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement

  CHRISTINE D. VALAN, JENS E. SLAGSVOLD, TARJE ONSØIEN HALVORSEN, MARTIN HERJE, ROY M. BREMNES, PAAL F. BRUNSVIG, ODD T. BRUSTUGUN, ØYSTEIN FLØTTEN, NINA LEVIN, STEIN H. SUNDSTRØM and BJØRN H. GRØNBERG

  Anticancer Research February 2018, 38 (2) 871-876;
• You have access

  Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer

  MINAKO NAWA-NISHIGAKI, RYO KOBAYASHI, AKIO SUZUKI, CHIEMI HIROSE, RIE MATSUOKA, RYUTARO MORI, MANABU FUTAMURA, TADASHI SUGIYAMA, KAZUHIRO YOSHIDA and YOSHINORI ITOH

  Anticancer Research February 2018, 38 (2) 877-884;
• You have access

  A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer

  JUN-ICHI SAITOH, KATSUYUKI SHIRAI, TAKANORI ABE, NOBUTERU KUBO, TAKESHI EBARA, TATSUYA OHNO, KOICHI MINATO, RYUSEI SAITO, MASANOBU YAMADA, TAKASHI NAKANO and THE WORKING GROUP OF THE LUNG TUMOR

  Anticancer Research February 2018, 38 (2) 885-891;
• You have access

  Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer

  MASAYUKI YANAGI, KEN SASAKI, YASUTO UCHIKADO, ITARU OMOTO, TAKAAKI ARIGAMI, HIROSHI KURAHARA, YOSHIKAZU UENOSONO, MASAHIKO SAKODA, KOSEI MAEMURA and SHOJI NATSUGOE

  Anticancer Research February 2018, 38 (2) 893-900;
• You have access

  Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?

  CARSTEN NIEDER, THOMAS A. KÄMPE and KIRSTEN ENGLJÄHRINGER

  Anticancer Research February 2018, 38 (2) 901-904;
• You have access

  Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

  TAKAAKI FUJII, JUN HORIGUCHI, YASUHIRO YANAGITA, YUKIO KOIBUCHI, FUMIHIRO IKEDA, NOBUYUKI UCHIDA, MORIHIKO KIMURA and GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG)

  Anticancer Research February 2018, 38 (2) 905-909;
• You have access

  Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil

  MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, MASAKAZU TAKAHASHI, KEISUKE IHARA, YOSUKE SHIDA, EIGO KURAYAMA, HIDEO OGATA, SATORU YAMAGUCHI, KINRO SASAKI, MAKOTO SAKAI, MAKOTO SOHDA, TATSUYA MIYAZAKI, HIROYUKI KUWANO and HIROYUKI KATO

  Anticancer Research February 2018, 38 (2) 911-918;
• You have access

  Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis

  CARLOS A. RUBIO, GIOVANNI DE PETRIS and GIACOMO PUPPA

  Anticancer Research February 2018, 38 (2) 919-921;
• You have access

  Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre

  EMMANOUIL KALAMPOKAS, HELENA YOUNG, ANTONINA BEDNAREK, MOHAMMAD HABIB, DAVID E. PARKIN, MAHALAKSHMI GURUMURTHY and MARY CAIRNS

  Anticancer Research February 2018, 38 (2) 923-928;
• You have access

  Low-dose Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) as an Alternative Therapy for Pleuropulmonary Involvement in Pseudomyxoma Peritonei

  MANUELA ROBELLA, MARCO VAIRA, ALICE BORSANO, CLAUDIO MOSSETTI and MICHELE DE SIMONE

  Anticancer Research February 2018, 38 (2) 929-932;
• You have access

  Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy

  MAKOTO SAKAI, MAKOTO SOHDA, TATSUYA MIYAZAKI, TOMONORI YOSHIDA, YUJI KUMAKURA, HIROAKI HONJO, KEIGO HARA, DAIGO OZAWA, SHIGEMASA SUZUKI, NARITAKA TANAKA, TAKEHIKO YOKOBORI and HIROYUKI KUWANO

  Anticancer Research February 2018, 38 (2) 933-938;
• You have access

  High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer

  KAZUNOBU SUZUKI, AKIRA WATANABE, KENICHIRO ARAKI, TAKEHIKO YOKOBORI, NORIHUMI HARIMOTO, DORGORMAA GANTUMUR, KEI HAGIWARA, TAKAHIRO YAMANAKA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, NORIO KUBO, NAVCHAA GOMBODORJ, MASAHIKO NISHIYAMA, YASUO HOSOUCHI, HIROYUKI KUWANO and KEN SHIRABE

  Anticancer Research February 2018, 38 (2) 939-944;
• You have access

  Clinical Assessment of Micro-residual Tumors during Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

  KENJI UEMOTO, HIROSHI DOI, HIROYA SHIOMI, KOICHI YAMADA, DAISAKU TATSUMI, TAKU YASUMOTO, MASAAKI TAKASHINA, MASAHIKO KOIZUMI and RYOONG-JIN OH

  Anticancer Research February 2018, 38 (2) 945-954;
• You have access

  The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma

  SHOKO YOSHIDA, TSUYOSHI SHIMO, YURIKA MURASE, KIYOFUMI TAKABATAKE, KOJI KISHIMOTO, SOICHIRO IBARAGI, NORIE YOSHIOKA, TATSUO OKUI, HITOSHI NAGATSUKA and AKIRA SASAKI

  Anticancer Research February 2018, 38 (2) 955-962;
• You have access

  Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities

  MASAKATSU NUMATA, SHO SAWAZAKI, JUNYA MORITA, YUKIO MAEZAWA, SHINYA AMANO, TORU AOYAMA, TSUTOMU SATO, TAKASHI OSHIMA, HIROYUKI MUSHIAKE, NORIO YUKAWA, MANABU SHIOZAWA, YASUSHI RINO and MUNETAKA MASUDA

  Anticancer Research February 2018, 38 (2) 963-967;
• You have access

  Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s²) DWI for Response Assessment in Rectal Cancer

  DANIEL HAUSMANN, JING LIU, JOHANNES BUDJAN, MIRIAM REICHERT, MELISSA ONG, MATHIAS MEYER, ARMAN SMAKIC, ROBERT GRIMM, RALPH STRECKER, STEFAN O. SCHOENBERG, XIAOYING WANG and ULRIKE I. ATTENBERGER

  Anticancer Research February 2018, 38 (2) 969-978;
• You have access

  Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging

  HITOSHI TATEBE, HIROSHI DOI, KAZUKI ISHIKAWA, HISATO KAWAKAMI, MASAKI YOKOKAWA, KIYOSHI NAKAMATSU, SHUICHI KANAMORI, TORU SHIBATA, MUTSUKAZU KITANO and YASUMASA NISHIMURA

  Anticancer Research February 2018, 38 (2) 979-986;
• You have access

  Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma

  NOBUHIRO SAITO, YOSHIHIRO SHIRAI, TAKASHI HORIUCHI, HIROSHI SUGANO, HIROAKI SHIBA, TARO SAKAMOTO, TADASHI UWAGAWA and KATSUHIKO YANAGA

  Anticancer Research February 2018, 38 (2) 987-992;
• You have access

  Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion

  TAKAHIDE SHINAGAWA, KEISUKE HATA, TEPPEI MORIKAWA, HIROTOSHI TAKIYAMA, KENSUKE OTANI, TAKESHI NISHIKAWA, TOSHIAKI TANAKA, TOMOMICHI KIYOMATSU, KAZUSHIGE KAWAI, HIROAKI NOZAWA, SOICHIRO ISHIHARA, HISASHI NAKAMURA, MASASHI FUKAYAMA and TOSHIAKI WATANABE

  Anticancer Research February 2018, 38 (2) 993-1002;
• You have access

  Patients with Increased Levels of the Oxidative Stress Biomarker SOD1 Appear to Have Diminished Postoperative Pain After Midline Laparotomy: A Randomised Trial with Special Reference to Postoperative Pain Score (NRS)

  JARI KÄRKKÄINEN, TUOMAS SELANDER, MARTIN PURDY, PETRI JUVONEN and MATTI ESKELINEN

  Anticancer Research February 2018, 38 (2) 1003-1008;
• You have access

  Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial

  DIRK RADES, ANTONIO J. CONDE-MORENO, JON CACICEDO, BARBARA ŠEGEDIN, KARMEN STANIC, MICHAELA METZ, VOLKER RUDAT and STEVEN E. SCHILD

  Anticancer Research February 2018, 38 (2) 1009-1015;
• You have access

  Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma

  HIROTAKA KONISHI, HITOSHI FUJIWARA, ATSUSHI SHIOZAKI, KATSUTOSHI SHODA, TOSHIYUKI KOSUGA, TAKESHI KUBOTA, KAZUMA OKAMOTO and EIGO OTSUJI

  Anticancer Research February 2018, 38 (2) 1017-1023;
• You have access

  Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma

  TIM SATTLER, CHRISTINA BREDT, STEFANIE SURWALD, CHRISTIAN RUST, JOHANNES RIEGER and TOBIAS JAKOBS

  Anticancer Research February 2018, 38 (2) 1025-1032;
• You have access

  Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care

  MASAHARU HATA, IZUMI KOIKE, ETSUKO MIYAGI, MIKIKO ASAI-SATO, HISASHI KAIZU, YUKI MUKAI, SHOKO TAKANO, EIKO ITO, MADOKA SUGIURA and TOMIO INOUE

  Anticancer Research February 2018, 38 (2) 1033-1040;
• You have access

  Which Primary Organ Is Most Suitable for Performing Pulmonary Metastasectomy?

  FUMIHIKO HIRAI, IKUHIKO KINOSHITA, TAICHI MATSUBARA, NAOKI HARATAKE, YUKA KOUZUMA, SHINKICHI TAKAMORI, TAKAI AKAMINE, GOUJI TOYOKAWA, TETSUZO TAGAWA, MITSUHIRO TAKENOYAMA and YOSHIHIKO MAEHARA

  Anticancer Research February 2018, 38 (2) 1041-1045;
• You have access

  Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period

  MASAYO TSUKAMOTO, YO-ICHI YAMASHITA, KATSUNORI IMAI, NAOKI UMEZAKI, TAKANOBU YAMAO, TAKAYOSHI KAIDA, KOSUKE MIMA, SHIGEKI NAKAGAWA, DAISUKE HASHIMOTO, AKIRA CHIKAMOTO, TAKATOSHI ISHIKO and HIDEO BABA

  Anticancer Research February 2018, 38 (2) 1047-1052;
• You have access

  Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation

  KATSUNORI IMAI, YO-ICHI YAMASHITA, TOSHIHIKO YUSA, YOSUKE NAKAO, RUMI ITOYAMA, SHIGEKI NAKAGAWA, HIROHISA OKABE, AKIRA CHIKAMOTO, TAKATOSHI ISHIKO and HIDEO BABA

  Anticancer Research February 2018, 38 (2) 1053-1060;
• You have access

  Visceral Adipose Tissue and Skeletal Muscle Index Distribution Predicts Severe Pancreatic Fistula Development After Pancreaticoduodenectomy

  HIROAKI YAMANE, TOMOYUKI ABE, HIRONOBU AMANO, KEIJI HANADA, TOMOYUKI MINAMI, TSUYOSHI KOBAYASHI, TOSHIKATSU FUKUDA, SHUJI YONEHARA, MASAHIRO NAKAHARA, HIDEKI OHDAN and TOSHIO NORIYUKI

  Anticancer Research February 2018, 38 (2) 1061-1066;
• You have access

  Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma

  YOUNG WHA KOH, SEONG YONG PARK, SEUNG HYUP HYUN and SU JIN LEE

  Anticancer Research February 2018, 38 (2) 1067-1071;
• You have access

  Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans

  CRISTA E. HORTON, MOHAMED KAMAL, MACALL LESLIE, ROY ZHANG, TAKEMI TANAKA and MOHAMMAD RAZAQ

  Anticancer Research February 2018, 38 (2) 1073-1076;
• You have access

  Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung Cancer

  YASUHIRO KATO, JUMPEI KASHIMA, KAGEAKI WATANABE, MAKIKO YOMOTA, YOSITAKA ZENKE, YUSUKE OKUMA, YUKIO HOSOMI, AKIHIKO GEMMA, MASAHIRO SEIKE and TATSURU OKAMURA

  Anticancer Research February 2018, 38 (2) 1077-1083;
• You have access

  Intensity and Pattern of Enhancement on CESM: Prognostic Significance and its Relation to Expression of Podoplanin in Tumor Stroma – A Preliminary Report

  ELZBIETA LUCZYNSKA, JOANNA NIEMIEC, SYLWIA HEINZE, AGNIESZKA ADAMCZYK, ALEKSANDRA AMBICKA, PAULINA MARCYNIUK, WOJCIECH RUDNICKI, JERZY W. MITUS, SONIA DYCZEK, JANUSZ RYS and BEATA SAS-KORCZYNSKA

  Anticancer Research February 2018, 38 (2) 1085-1095;
• You have access

  Fibrinogen Levels Are Associated with Lymph Node Involvement and Overall Survival in Gastric Cancer Patients

  JÚLIUS PALAJ, ŠTEFAN KEČKÉŠ, VÍTĚZSLAV MAREK, DANIEL DYTTERT, IVETA WACZULÍKOVÁ and ŠTEFAN DURDÍK

  Anticancer Research February 2018, 38 (2) 1097-1104;
• You have access

  Is Ki-67 of Diagnostic Value in Distinguishing Between Partial and Complete Hydatidiform Moles? A Systematic Review and Meta-analysis

  YUE ZHAO, GUANG-WU XIONG, XIAO-WEI ZHANG and BO HANG

  Anticancer Research February 2018, 38 (2) 1105-1110;